Stock listing

BOATS:SERA Sera Prognostics, Inc. Stock

US listing (BOATS) of Sera Prognostics, Inc. · home listing NASDAQ:SERA

Follow Sera Prognostics, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:SERA

$1.81 USD -0.10 (-5.2%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SERA

Past year -42.2% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.80 – $1.87 USDNov 20, 2026
Volume
94,600 sharesNov 20, 2026
Market cap
$69.65M USDAt the close on Nov 20, 2026 · price × 38.48M shares outstanding
52-week range
$1.56 – $3.85 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$55,934 USDMedian day 16,867 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Sera Prognostics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SERA · Home$1.81 USD-0.10 (-5.2%)94,600$1.821$1.87$1.80$1.91Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SERA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.81-0.10-5.2%$1.821$1.87$1.8094,600
$1.91-0.09-4.5%$2.00$2.00$1.89510,451
$2.00+0.06+3.1%$1.92$2.005$1.9135,253
$1.94-0.07-3.5%$2.13$2.14$1.9225,532
$2.01+0.03+1.5%$1.96$2.04$1.9528,138
$1.98+0.04+2.1%$1.97$2.055$1.9218,791
$1.94-0.05-2.5%$2.05$2.05$1.9184,541
$1.99-0.20-9.1%$2.175$2.175$1.96553,388
$2.190.000.0%$2.01$2.218$2.0130,378
$2.19+0.11+5.3%$2.08$2.22$2.00218,745
$2.08+0.065+3.2%$2.00$2.08$2.0021,631
$2.015+0.085+4.4%$1.96$2.058$1.9693,572
$1.93-0.06-3.0%$1.96$2.05$1.9314,951
$1.99-0.05-2.5%$2.05$2.07$1.9622,566
$2.04-0.02-1.0%$2.09$2.09$2.0385,986
$2.06+0.03+1.5%$2.095$2.095$2.0316,867
$2.03-0.02-1.0%$2.03$2.03$2.03516
$2.05+0.01+0.5%$2.04$2.07$2.0313,568
$2.04+0.01+0.5%$2.039$2.08$2.0325,414
$2.03-0.01-0.5%$2.04$2.10$2.0325,000
$2.04+0.01+0.5%$2.03$2.04$2.0331,200
$2.030.000.0%$2.03$2.045$2.0324,200
$2.030.000.0%$2.06$2.06$2.02531,300
$2.03-0.03-1.5%$2.04$2.065$2.035,300
$2.06+0.03+1.5%$2.03$2.061$2.033,500
$2.03-0.04-1.9%$2.07$2.09$2.0313,300
$2.07+0.03+1.5%$2.03$2.07$2.035,800
$2.04-0.03-1.4%$2.04$2.047$2.034,700
$2.07+0.03+1.5%$2.06$2.099$2.0313,800
$2.04+0.02+1.0%$2.01$2.10$2.016,300
$2.02-0.05-2.4%$2.21$2.21$2.0113,400
$2.07+0.02+1.0%$2.01$2.07$2.01800
$2.05+0.05+2.5%$2.12$2.12$2.024,400
$2.00-0.09-4.3%$2.08$2.15$2.0022,900
$2.09+0.05+2.5%$2.04$2.15$2.0421,900
$2.04-0.05-2.4%$2.05$2.06$2.026,700
$2.09+0.08+4.0%$2.01$2.12$2.0111,500
$2.01-0.01-0.5%$2.075$2.075$2.014,300
$2.02-0.02-1.0%$2.02$2.043$2.016,900
$2.04-0.07-3.3%$2.085$2.085$2.0012,800
$2.11+0.05+2.4%$2.14$2.14$2.075,400
$2.06-0.07-3.3%$2.13$2.20$2.0613,900
$2.13+0.01+0.5%$2.13$2.175$2.1210,410
$2.12+0.035+1.7%$2.12$2.20$2.1217,003
$2.085+0.015+0.7%$2.07$2.16$2.0792,100
$2.07+0.05+2.5%$2.08$2.08$2.047,200
$2.02+0.03+1.5%$2.04$2.04$2.0010,900
$1.99-0.01-0.5%$1.97$2.02$1.9625,500
$2.00-0.03-1.5%$2.035$2.06$1.98731,800
$2.03-0.02-1.0%$2.05$2.055$1.99726,400
$2.05+0.05+2.5%$2.00$2.06$1.99572,100
$2.00-0.01-0.5%$2.01$2.06$2.008,300
$2.01-0.01-0.5%$2.00$2.04$1.9864,100
$2.02+0.04+2.0%$2.00$2.05$1.9710,500
$1.98-0.03-1.5%$2.03$2.06$1.9815,300
$2.01-0.07-3.4%$2.01$2.18$1.9715,400
$2.08-0.04-1.9%$2.09$2.16$2.0814,700
$2.12+0.05+2.4%$2.08$2.177$2.089,500
$2.07+0.04+2.0%$2.07$2.09$2.0523,100
$2.03-0.06-2.9%$2.11$2.20$1.9851,400
$2.09-0.09-4.1%$2.18$2.18$2.097,300
$2.180.000.0%$2.12$2.21$2.1217,800
$2.18+0.04+1.9%$2.14$2.211$2.0619,400
$2.14+0.04+1.9%$2.09$2.16$2.08514,500
$2.10+0.11+5.5%$1.99$2.10$1.9930,900
Ticker
BOATS:SERA
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Sera Prognostics, Inc. news

Sera Prognostics, Inc. on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
17 in the last 12 months · 92 in all · newest Nov 4, 2026 · oldest 2021
Calls
21 calls with a replay · 21 with a transcript · latest Nov 4, 2026
Decks
10 decks · latest Nov 4, 2026

Where Sera Prognostics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SERA · Home listingNASDAQUnited StatesUSD
BOATS:SERA · This pageBOATSUnited StatesUSD

Valuation

EV/sales 300× against a median of 4.9×: the highest of 11 Diagnostics & research services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$28.84M USD
P/E
Loss
EV/sales
300×
EV/EBITDA
Negative EBITDA
Price/book
1.3×
Gross margin
−103.1%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
0.1×
Beta vs S&P 500
0.57

Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Sera Prognostics, Inc. · NASDAQ:SERAUS$69.65MUS$28.84Mn/a300×n/a1.3×n/a0.1×0.57
Nightingale Health Oyj Class B · OMXHEX:HEALTHUS$77.17MUS$36.79Mn/a6.1×n/a1.4×−335.7%0.0×n/a
Lucid Diagnostics Inc. · NASDAQ:LUCDUS$77.14MUS$77.63Mn/a14.3×n/a13.0×−892.8%3.1×1.36
Seer, Inc. · NASDAQ:SEERUS$75.91M−US$58.25Mn/a−4.1×n/a0.4×−450.9%0.1×1.03
Selvita SA · GPW:SLVUS$75.22MUS$113.4Mn/a1.4×9.1×1.0×−0.6%0.5×n/a
BioPorto A/S · OMXCOP:BIOPORUS$68.30MUS$58.06M53.8×10.7×n/a5.7×23.3%0.1×n/a
Nanoform Finland Oyj · OMXHEX:NANOFHUS$66.63MUS$52.80Mn/a11.9×n/a1.7×−339.1%0.2×n/a
Applied BioCode Corp. · TWSE:6598US$64.88MUS$49.53Mn/a2.5×n/a3.0×−7.3%0.1×n/a
Insight Molecular Diagnostics Inc. · NASDAQ:IMDXUS$64.53MUS$55.70Mn/a28.3×n/an/an/an/a1.77
Gentian Diagnostics ASA · OSL:GENTUS$62.79MUS$53.42Mn/a2.7×38.0×3.2×−2.6%0.0×n/a
Prestige Biologics Co., Ltd. · KRX:334970US$61.06MUS$72.08Mn/a3.6×n/a0.9×−192.1%0.2×n/a
Median of the othersUS$67.46MUS$54.56M53.8×4.9×23.5×1.7×−192.1%0.1×1.36

Forecasts

4 strong buy · Analysts' consensus from EODHD, read Nov 19, 2026. Not 6ix's view and not investment advice.

Price target
5.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.66 · 3 analysts
Revenue, year to Dec 2026
200K · 3 analysts

Team and board

Officers

OfficerRole
Zhenya LindgardtPresident and CEO
Scott GleasonChief Financial Officer
Benjamin G. JacksonGeneral Counsel​​
Jennifer ZibudaHead of Investor Relations
Angie FoxVP of Clinical Operations
Nikki MartinVP of Quality and Regulatory
Tiffany InglisChief Medical Officer & VP Medical Affairs
Adrienne LugoHead of Sales & Strategic Accounts
Cassondra MizeHead of Marketing
Jay BonifaceChief Scientific Officer​
Lee AndersonChief Commercial Officer
Liana BurnsHead of Payer, Government & Strategic Partnerships

Board

DirectorRole
Mark CaponeDirector

Events

Next results
Mar 17, 2027 (expected)

Calls

CallWhenStatus
Sera Prognostics (NASDAQ:SERA) Q3 2026 Earnings CallWed, Nov 04, 2026 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q2 2026 Earnings CallWed, Aug 12, 2026 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q1 2026 Earnings CallWed, May 06, 2026 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q4 2025 Earnings CallWed, Mar 18, 2026 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q3 2025 Earnings CallThu, Nov 13, 2025 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q2 2025 Earnings CallWed, Aug 06, 2025 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q1 2025 Earnings CallWed, May 07, 2025 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q4 2024 Earnings CallWed, Mar 19, 2025 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q3 2024 Earnings CallWed, Nov 06, 2024 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q2 2024 Earnings CallWed, Aug 07, 2024 · 5:00 PM ETReplay
All 21 calls
CallWhenStatus
Sera Prognostics (NASDAQ:SERA) Q1 2024 Earnings CallWed, May 08, 2024 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q4 2023 Earnings CallWed, Mar 20, 2024 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q3 2023 Earnings CallWed, Nov 08, 2023 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q2 2023 Earnings CallWed, Aug 09, 2023 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q1 2023 Earnings CallWed, May 10, 2023 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q4 2022 Earnings CallWed, Mar 22, 2023 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q3 2022 Earnings CallWed, Nov 09, 2022 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q2 2022 Earnings CallWed, Aug 10, 2022 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q1 2022 Earnings CallTue, May 10, 2022 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q4 2021 Earnings CallTue, Mar 29, 2022 · 5:00 PM ETReplay
Sera Prognostics (NASDAQ:SERA) Q3 2021 Earnings CallTue, Nov 09, 2021 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 4, 2026 · After close+3.2%
Q2 2026Aug 12, 2026 · After close−0.5%
Q1 2026May 6, 2026 · After close+6.1%
Q4 2025Mar 25, 2026−2.0%
Q3 2025Nov 13, 2025 · After close+0.3%
Q2 2025Aug 6, 2025 · After close−5.5%
Q1 2025May 7, 2025 · After close−11.7%
Q4 2024Mar 19, 2025−3.7%
Q3 2024Nov 6, 2024 · After close−12.7%
Q2 2024Aug 7, 2024 · After close+0.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+5.3%
Q4 2023Mar 20, 2024 · After close+3.8%
Q3 2023Nov 8, 2023 · After close−7.6%
Q2 2023Aug 9, 2023 · After close+3.2%
Q1 2023May 10, 2023 · After close+0.6%
Q4 2022Mar 22, 2023 · After close−6.8%
Q3 2022Nov 9, 2022 · After close+10.8%
Q2 2022Aug 10, 2022 · After close+2.8%
Q1 2022May 10, 2022 · After close−7.1%
Q4 2021Mar 29, 2022 · After close−7.7%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings15 slidesNov 4, 2026
Q2 2026 Earnings PresentationEarnings38 slidesAug 12, 2026
Q4 2025 Earnings PresentationEarnings38 slidesMar 18, 2026
Investor Presentation (January 2026)Investor deck38 slidesJan 8, 2026
Investor Presentation (September 2025)Investor deck31 slidesSep 5, 2025
Technical Presentation (March 2025)Technical25 slidesMar 19, 2025
Corporate Update (January 2025)Corporate update39 slidesJan 31, 2025
Investor Presentation (January 2025)Investor deck34 slidesJan 13, 2025
Investor Presentation (March 2024)Investor deck31 slidesMar 20, 2024
Corporate Update (September 2023)Corporate update40 slidesSep 25, 2023

Open Decks

Financings

RaiseDate
Public offering of class A common stock and pre-funded warrants
Announced: about US$50M · US$4 a share · Jefferies +3
Dealers: Jefferies (co-lead), TD Cowen (co-lead), William Blair (co-lead), RBC Capital Markets
Use of proceeds: Expand US commercial infrastructure, prepare EU expansion, fund PreTRM adoption studies including a potential FDA submission, and general corporate purposes
Feb 10, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$16.00 a share on Jul 14, 2021.

Price
US$16.00 a share
Shares offered
4,687,500 shares of Class A common stock
Offering size
US$75 million
Underwriters' option
Up to 703,125 more shares
Listing
SERA on the Nasdaq Global Market
Underwriters
Citigroup, Cowen, William Blair · In the order on the cover
Shares delivered
On or about Jul 19, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceMar 29, 2021
Filed publiclyJun 11, 2021
Amended onceJul 8, 2021
Shares registered with an exchangeJul 14, 2021
Declared effective by the SECJul 14, 2021
Final prospectus, with the priceJul 16, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 16, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue81.0K77.0K306.0K268.0K82.0K25.0K36.0K
Cost of revenue164.0K82.0K210.0K193.0K37.0K11.0K18.0K
Gross profit-83.0K-5.00K96.0K75.0K45.0K14.0K18.0K
Research and development13.2M14.7M15.2M14.2M11.0M7.78M9.35M
Selling, general and administrative16.7M16.1M16.3M16.8M14.1M6.56M4.28M
Operating income-36.5M-36.6M-39.8M-45.7M-35.4M-18.0M-16.6M
Depreciation and amortization940.0K833.0K900.0K756.0K659.0K895.0K946.0K
EBITDA-35.6M-35.8M-38.9M-44.9M-34.7M-17.1M-15.6M
Interest expense9.00K28.0K55.0K61.0K746.0K1.84M1.97M
Income before tax-31.9M-32.9M-36.2M-44.2M-35.0M-19.8M-16.5M
Income tax0000003.92M
Net income-31.9M-32.9M-36.2M-44.2M-35.0M-19.8M-16.5M
Earnings per share, basic-0.67-0.99-1.16-1.43-2.33-12.76-0.91
Earnings per share, diluted-0.67-0.99-1.16-1.43-2.33-12.76

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents3.94M4.04M3.88M29.9M58.9M13.5M21.4M
Short-term investments35.3M42.2M45.2M52.8M46.2M0
Receivables12.0K34.0K160.0K113.0K27.0K2.00K1.00K
Inventory11
Current assets40.8M47.6M61.3M90.1M110.3M13.7M21.6M
Property, plant and equipment1.77M965.0K1.64M
Total assets101.9M72.6M95.4M116.3M147.0M14.8M23.3M
Accounts payable862.0K1.97M1.05M1.55M1.20M441.0K748.0K
Current liabilities24.2M24.8M24.4M15.5M8.41M11.2M5.90M
Long-term debt348.0K5.44M
Total debt2.34M840.0K1.86M2.83M128.0K8.57M9.31M
Total liabilities26.5M24.8M25.3M17.4M8.46M12.3M12.3M
Shareholders' equity75.4M47.8M70.2M98.9M138.6M-125.6M11.0M
Shares outstanding47.7M33.2M31.2M30.9M30.8M18.1M18.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-25.6M-14.2M-27.2M-34.6M-31.6M-16.9M-19.3M
Capital spending-726.0K-56.0K-128.0K-791.0K-1.30M-149.0K-109.0K
Free cash flow-26.3M-14.2M-27.3M-35.4M-32.9M-17.0M-19.4M
Cash from investing-28.5M11.7M438.0K5.55M-82.6M-149.0K-6.00K
Cash from financing54.0M2.61M752.0K5.00K159.6M9.16M33.0M
Share buybacks308.0K167.3M
Change in cash-99.0K163.0K-26.0M-29.1M45.4M-7.86M13.7M

Open Financials

Filings

FilingDateTypeFiled with
10-Q · Quarterly reportNov 4, 2026Quarterly reportSEC
8-K · Current reportNov 4, 2026ResultsSEC
4 · Change in ownershipOct 13, 2026Insider tradeSEC
144 · Notice of proposed saleOct 13, 2026Other filingsSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
4 · Change in ownershipSep 11, 2026Insider tradeSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
144 · Notice of proposed saleSep 11, 2026Other filingsSEC
4 · Change in ownershipSep 9, 2026Insider tradeSEC
144 · Notice of proposed saleSep 9, 2026Other filingsSEC
144 · Notice of proposed saleSep 9, 2026Other filingsSEC
4 · Change in ownershipSep 2, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
3 · Initial statement of ownershipSep 1, 2026Insider tradeSEC
8-K · Current reportAug 19, 2026Management or board changeSEC
10-Q · Quarterly reportAug 12, 2026Quarterly reportSEC
8-K · Current reportAug 12, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 15, 2026Big-stake noticeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
4 · Change in ownershipJul 14, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 1, 2026Insider tradeSEC
8-K · Current reportJun 30, 2026Management or board changeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
4 · Change in ownershipJun 15, 2026Insider tradeSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
144 · Notice of proposed saleJun 15, 2026Other filingsSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
4 · Change in ownershipJun 10, 2026Insider tradeSEC
144 · Notice of proposed saleJun 10, 2026Other filingsSEC
144 · Notice of proposed saleJun 10, 2026Other filingsSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
144 · Notice of proposed saleJun 8, 2026Other filingsSEC
8-K · Current reportJun 4, 2026Meeting outcomeSEC
4 · Change in ownershipJun 4, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJun 1, 2026Meeting noticeSEC
8-K · Current reportJun 1, 2026Management or board changeSEC
144 · Notice of proposed saleMay 12, 2026Other filingsSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 1, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 24, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 24, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 24, 2026Meeting noticeSEC
144 · Notice of proposed saleApr 21, 2026Other filingsSEC
144 · Notice of proposed saleMar 24, 2026Other filingsSEC
424B5 · ProspectusMar 18, 2026Offer documentSEC
S-8 · Registration statement for employee plansMar 18, 2026Offer documentSEC
10-K · Annual reportMar 18, 2026Annual reportSEC
8-K · Current reportMar 18, 2026ResultsSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 13, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
144 · Notice of proposed saleMar 12, 2026Other filingsSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
144 · Notice of proposed saleMar 10, 2026Other filingsSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
144 · Notice of proposed saleFeb 24, 2026Other filingsSEC
4 · Change in ownershipFeb 4, 2026Insider tradeSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
144 · Notice of proposed saleJan 27, 2026Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJan 16, 2026Big-stake noticeSEC
8-K · Current reportJan 8, 2026Current reportSEC
8-K · Current reportJan 7, 2026Current reportSEC
4 · Change in ownershipDec 30, 2025Insider tradeSEC
144 · Notice of proposed saleDec 30, 2025Other filingsSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
4 · Change in ownershipDec 11, 2025Insider tradeSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
4 · Change in ownershipDec 10, 2025Insider tradeSEC
144 · Notice of proposed saleDec 10, 2025Other filingsSEC
144 · Notice of proposed saleDec 10, 2025Other filingsSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
144 · Notice of proposed saleDec 8, 2025Other filingsSEC
4 · Change in ownershipDec 5, 2025Insider tradeSEC
144 · Notice of proposed saleDec 5, 2025Other filingsSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
4 · Change in ownershipDec 3, 2025Insider tradeSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
144 · Notice of proposed saleDec 2, 2025Other filingsSEC
4 · Change in ownershipNov 26, 2025Insider tradeSEC
144 · Notice of proposed saleNov 26, 2025Other filingsSEC
8-K · Current reportNov 24, 2025Current reportSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
4 · Change in ownershipNov 12, 2025Insider tradeSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
144 · Notice of proposed saleNov 12, 2025Other filingsSEC
4 · Change in ownershipNov 6, 2025Insider tradeSEC
144 · Notice of proposed saleNov 6, 2025Other filingsSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
144 · Notice of proposed saleNov 4, 2025Other filingsSEC
4 · Change in ownershipOct 15, 2025Insider tradeSEC
3 · Initial statement of ownershipOct 15, 2025Insider tradeSEC
4 · Change in ownershipOct 8, 2025Insider tradeSEC
144 · Notice of proposed saleOct 7, 2025Other filingsSEC
4 · Change in ownershipOct 6, 2025Insider tradeSEC
144 · Notice of proposed saleOct 6, 2025Other filingsSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
144 · Notice of proposed saleSep 12, 2025Other filingsSEC
4/A · Change in ownership, amendedSep 11, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
4 · Change in ownershipSep 9, 2025Insider tradeSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
144 · Notice of proposed saleSep 9, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeSep 8, 2025Big-stake noticeSEC
4 · Change in ownershipSep 5, 2025Insider tradeSEC
144 · Notice of proposed saleSep 5, 2025Other filingsSEC
8-K · Current reportSep 5, 2025Current reportSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
4 · Change in ownershipSep 2, 2025Insider tradeSEC
144 · Notice of proposed saleAug 29, 2025Other filingsSEC
4 · Change in ownershipAug 20, 2025Insider tradeSEC
144 · Notice of proposed saleAug 20, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC
4 · Change in ownershipAug 11, 2025Insider tradeSEC

This page holds 200 of 660 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Sera Prognostics, Inc.’s releases · as of Feb 10, 2025

Common shares
38,481,707
Fully diluted
38,481,707

Fully diluted

LineShares
Common shares38,481,707

Share count over time

CountShares
Nov 22, 202638,481,707

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
Baker Bros. Advisors LP5.5M14.3%US$11.5MNo changeNov 16, 2026
Whetstone Capital Advisors, LLC3.31M8.6%US$6.91MNo changeNov 16, 2026
abrdn2.95M7.7%US$6.17M+200KNov 10, 2026
PSP Research LLC2.4M6.2%US$5.01MNewOct 21, 2026
Vivo Capital, LLC1.65M4.3%US$3.45MNo changeNov 13, 2026
Vanguard1.52M3.9%US$3.17M+37,341Nov 13, 2026
Geode Capital349K0.91%US$730KNo changeNov 6, 2026
Sanders Morris Harris LLC315K0.82%US$642KNewOct 14, 2026
Captrust Financial Advisors307K0.80%US$641K−229KNov 12, 2026
BlackRock223K0.58%US$467K+2,005Nov 13, 2026
All 46 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
AWM Investment Company, Inc.207K0.54%US$433KNo changeNov 13, 2026
State Street125K0.32%US$261KNo changeNov 12, 2026
Perigon Wealth Management, LLC72,6850.19%US$152KNo changeOct 22, 2026
Northern Trust68,5950.18%US$143KNo changeNov 16, 2026
Millennium61,9490.16%US$129K−12,037Nov 16, 2026
BNY60,9270.16%US$127KNo changeNov 5, 2026
Requisite Capital Management, LLC55,6480.14%US$116KNo changeNov 10, 2026
Bridgeway Capital Management, LLC54,8560.14%US$115K−849Nov 16, 2026
Citadel50,2710.13%US$105K+8,860Nov 16, 2026
Empowered Funds, LLC50,2560.13%US$105KNewNov 13, 2026
Ballentine Partners, LLC49,6640.13%US$104KNo changeNov 13, 2026
Morgan Stanley48,5720.13%US$102K−2,400Nov 13, 2026
Goldman Sachs47,9740.12%US$100K+15,433Nov 16, 2026
Twelve Points Wealth Management LLC43,3880.11%US$88,512No changeNov 3, 2026
HighTower Advisors, LLC42,2340.11%US$88,269No changeNov 9, 2026
Dimensional27,9170.07%US$58,055−1,582Nov 4, 2026
Birch Hill Investment Advisors LLC27,2930.07%US$57,042No changeOct 16, 2026
Cetera Investment Advisers25,0000.06%US$52,250No changeNov 13, 2026
Stratos Wealth Partners, LTD.21,4880.06%US$44,910NewNov 13, 2026
Qube Research & Technologies Ltd16,3780.04%US$34,230−34,493Nov 13, 2026
Riverview Capital Advisers, LLC12,6810.03%US$26,504+12Nov 12, 2026
Wagner Wealth Management, LLC12,4000.03%US$25,916No changeOct 21, 2026
Focus Partners Wealth12,1560.03%US$25,406No changeNov 12, 2026
Geneos Wealth Management Inc.10,8000.03%US$22,572No changeNov 9, 2026
Diversify Advisory Services, LLC10,5900.03%US$21,286NewNov 17, 2026
Wealth Enhancement Advisory Services, LLC10,5000.03%US$21,210−4Oct 13, 2026
Fidelity2,471<0.01%US$5,165−68Nov 10, 2026
Global Retirement Partners, LLC1,000<0.01%US$2,090No changeNov 10, 2026
UBS886<0.01%US$1,851−10,423Nov 10, 2026
Toth Financial Advisory Corp255<0.01%US$533NewOct 8, 2026
JPMorgan222<0.01%US$446No changeNov 12, 2026
Nisa Investment Advisors, LLC129<0.01%US$270No changeOct 20, 2026
BNP Paribas96<0.01%US$201−90Nov 12, 2026
RBC46<0.01%+1Nov 16, 2026
Caitong International Asset Management Co., Ltd4<0.01%US$8No changeOct 29, 2026
SBI Securities Co., Ltd.4<0.01%US$8No changeOct 21, 2026

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund887K2.3%US$1.61MNo changeJun 30, 2026
Vanguard Extended Market Index Fund380K0.99%US$692K+75,757Jun 30, 2026
Fidelity Extended Market Index Fund173K0.45%US$373K+12,218May 31, 2026
iShares Micro-Cap ETF102K0.27%US$186K+23,149Jun 30, 2026
Ultra-Small Company Market Fund51,1050.13%US$93,011+10,000Jun 30, 2026
Fidelity Total Market Index Fund50,6390.13%US$109KNo changeMay 31, 2026
Fidelity Series Total Market Index Fund43,4690.11%US$93,893+1,355May 31, 2026
Fidelity Nasdaq Composite Index Fund23,1910.06%US$50,093No changeMay 31, 2026
Goldman Sachs Absolute Return Tracker Fund21,8360.06%US$39,742+11,380Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund18,7160.05%US$34,063NewJun 30, 2026
All 17 holders
HolderSharesOf the companyValueChangeAs of
Vanguard Balanced Index Fund11,8480.03%US$21,563No changeJun 30, 2026
1290 VT Micro Cap Portfolio6,9680.02%US$12,682+1,594Jun 30, 2026
Avantis U.S. Small Cap Equity ETF5,4030.01%US$11,670No changeMay 31, 2026
Dimensional US Core Equity 1 ETF5,1010.01%US$10,406NewJul 31, 2026
JNL/DFA U.S. Small Cap Fund3,288<0.01%US$5,984No changeJun 30, 2026
AST Small-Cap Equity Portfolio2,450<0.01%US$4,459No changeJun 30, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND174<0.01%US$355+17Jul 31, 2026

Insider trades

InsiderTradeSharesPriceValueDate
Inglis Tiffany Eul Davis
Officer: Chief Medical Officer
Sale8,024USD 2.03US$16,289Oct 12, 2026
Jackson Benjamin
Officer: General Counsel
Sale2,190USD 2.00US$4,380Sep 10, 2026
Lindgardt Zhenya
Director, Officer: Chief Executive Officer
Sale7,022USD 2.00US$14,044Sep 10, 2026
Anderson Dyaarl Lee Jr.
Officer: Chief Commercial Officer
Sale1,800USD 2.00US$3,600Sep 10, 2026
Inglis Tiffany Eul Davis
Officer: Chief Medical Officer
Sale486USD 2.00US$972Sep 10, 2026
Lindgardt Zhenya
Director, Officer: Chief Executive Officer
Sale20,139USD 2.00US$40,278Sep 8, 2026
Jackson Benjamin
Officer: General Counsel
Sale2,179USD 2.01US$4,380Jun 11, 2026
Lindgardt Zhenya
Director, Officer: Chief Executive Officer
Sale6,990USD 2.01US$14,050Jun 11, 2026
Aerts Austin
Officer: Chief Financial Officer
Sale2,037USD 2.01US$4,094Jun 11, 2026
Anderson Dyaarl Lee Jr.
Officer: Chief Commercial Officer
Sale4,739USD 2.01US$9,525Jun 11, 2026
All 14 trades
InsiderTradeSharesPriceValueDate
Inglis Tiffany Eul Davis
Officer: Chief Medical Officer
Sale362USD 2.01US$728Jun 11, 2026
Lindgardt Zhenya
Director, Officer: Chief Executive Officer
Sale20,755USD 2.08US$43,170Jun 9, 2026
Aerts Austin
Officer: Chief Financial Officer
Sale5,440USD 2.08US$11,315Jun 9, 2026
Lawrence Sandra AJ
Director
Sale1,560USD 2.15US$3,354Jun 8, 2026

Big stakes

HolderStakeSharesDate
Baker Bros. Advisors LP16.10%5.5MFeb 12, 2025
Whetstone Capital Advisors, LLC8.60%3.31MMar 31, 2026
Chione Ltd.7.60%2.61MFeb 11, 2025
Aberdeen Group plc7.21%2.75MJun 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jay M. Moyes
Other companies: BioCardia, Inc. (Board Member · Since at least Oct 24, 2016); SiNtx Technologies, Inc. (Audit Committee Chair · Since at least Feb 12, 2014); Puma Biotechnology Inc (Director · Since at least Apr 27, 2012); Achieve Life Sciences, Inc. (Director · Aug 1, 2017 – May 31, 2022 · Past); Osiris Therapeutics Inc (Director · Aug 3, 2006 – Feb 12, 2013 · Past); Myriad Genetics, Inc. (Chief Financial Officer · Feb 10, 2006 – Oct 15, 2007 · Past)
Chief Financial Officer · Jul 14, 2021 – Jun 7, 2023 · Past
Jeffrey Elliott
Other companies: ICON plc (Director · Since at least Jun 1, 2026); Quanterix Corporation (COO of Exact Sciences · Since at least Aug 19, 2024); Exagen Inc. (Director · Sep 18, 2019 – Jun 18, 2020 · Past); EXACT Sciences Corporation (Chief Financial Officer · Nov 8, 2016 – Apr 30, 2024 · Past)
Director · Since at least Mar 20, 2025
Kim Kamdar
Other companies: Evofem Biosciences, Inc. (Member of the Board of Directors · Since at least Nov 19, 2014); Singular Genomics Systems Inc (Director · May 26, 2021 – Feb 21, 2025 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past); Syndax Pharmaceuticals, Inc. (Director · Mar 2, 2016 – Oct 31, 2016 · Past)
Director · Since at least Jul 14, 2021
Sandra A.J. Lawrence
Other companies: Brixmor Property Group Inc. (Director · Since at least Dec 24, 2021); Evergy, Inc. (Director · Since at least Jun 4, 2018); American Shared Hospital Services (Director · Sep 7, 2017 – Jun 25, 2021 · Past); Westar Energy Inc (Director · Jan 3, 2006 – Jun 4, 2018 · Past)
Director · Since at least Nov 29, 2021
Douglas Carl Fisher
Other companies: CERo Therapeutics Holdings, Inc. (President · Oct 5, 2021 – Feb 14, 2024 · Past); Precipio, Inc. (Director · Sep 26, 2017 – Oct 27, 2023 · Past); Vyome Holdings, Inc. (Director · Oct 5, 2016 – Sep 16, 2020 · Past)
Chief Business Officer · Jul 14, 2021 – Jan 10, 2022 · Past
Jane F Barlow
Other companies: Viracta Therapeutics Inc (Director · Aug 14, 2021 – Jun 20, 2024 · Past); Momenta Pharmaceuticals Inc (Director · Dec 11, 2019 – Oct 1, 2020 · Past); TherapeuticsMD, Inc. (Director · Mar 27, 2018 – Aug 12, 2019 · Past)
Director · Since at least Apr 11, 2022
Mark Capone
Other companies: Mesa Laboratories, Inc. (Director · Since at least Jan 8, 2024); Constellation Alpha Capital Corp (Director · Jul 18, 2022 – Jun 1, 2023 · Past); Myriad Genetics, Inc. (President & C.E.O. · Aug 19, 2016 – Sep 30, 2019 · Past)
Director · Since at least Jun 30, 2026
Mansoor Raza Mirza
Other companies: Acrivon Therapeutics, Inc. (Chief Medical Officer · Since at least Apr 9, 2025); Karyopharm Therapeutics Inc. (Director · Since at least Nov 5, 2013)
Director · Since at least Jul 14, 2021
Benjamin G. Jackson
Other companies: Myriad Genetics, Inc. (Former E.V.P., General Counsel · Jul 1, 2019 – Apr 12, 2021 · Past)
General Counsel​​ · Since at least Jul 14, 2021
Gregory C Critchfield
Other companies: Myriad Genetics, Inc. (President Myriad Genetic Labs · Feb 16, 2006 – Sep 15, 2009 · Past)
Director · Since at least Jul 14, 2021
All 35 people
PersonSeat
Robert Gardner Harrison
Other companies: Myriad Genetics, Inc. (Chief Information Officer · Jan 1, 2008 – Sep 17, 2014 · Past)
Chief Information Officer · Since at least Nov 1, 2021
Scott Gleason
Other companies: OraSure Technologies, Inc. (Interim CFO/SVP IR · Sep 17, 2021 – May 21, 2022 · Past)
Chief Financial Officer · Since at least Aug 19, 2026
Adrienne LugoHead of Sales & Strategic Accounts · Since at least Nov 5, 2026
Angie FoxVP of Clinical Operations · Since at least Nov 5, 2026
Austin AertsChief Financial Officer · Since at least Jun 7, 2023
Cassondra MizeHead of Marketing · Since at least Nov 5, 2026
Dyaarl Lee Anderson JrChief Commercial Officer · Since at least May 19, 2025
Jay BonifaceChief Scientific Officer​ · Since at least Nov 5, 2026
Jeff ElliottDirector · Mar 19, 2025 – Nov 4, 2026 · Past
Jennifer ZibudaHead of Investor Relations · Since at least Aug 19, 2026
John J BonifaceChief Scientific Officer · Since at least Jul 14, 2021
John M PeltierSVP of Lab Operations · Jul 14, 2021 – Jul 14, 2021 · Past
Joshua PhillipsDirector · Since at least Jul 14, 2021
Lee AndersonChief Commercial Officer · Since at least May 8, 2025
Liana BurnsHead of Payer, Government & Strategic Partnerships · Since at least Nov 5, 2026
Marcus Dean WilsonDirector · Since at least Jul 14, 2021
Michael R FoleyChief Medical Officer · Dec 30, 2021 – Jul 12, 2023 · Past
Nadia AltomareChief Commercial Officer · Jul 14, 2021 – Jun 9, 2023 · Past
Nichole L MartinVP OF Q/R & HIPPA PRIV. OFF · Jul 14, 2021 – Jul 14, 2021 · Past
Nikki MartinVP of Quality and Regulatory · Since at least Nov 5, 2026
Paul KearneyChief Data Officer · Since at least Oct 1, 2021
Ryan TrimbleDirector · Since at least Jul 14, 2021
Thomas GariteVP, Clinical Sciences · Jul 14, 2021 – Aug 26, 2021 · Past
Tiffany InglisChief Medical Officer & VP Medical Affairs · Since at least Oct 1, 2025
Zhenya LindgardtPresident and CEO · Since at least Nov 8, 2021

Open People

Log in to ask 6ix AI your own questions about Sera Prognostics, Inc.